New Covenant Trust Company »

Apellis Pharmaceuticals shares owned by New Covenant Trust Company

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by New Covenant Trust Company from 13F filings

Historical chart of New Covenant Trust Company investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by New Covenant Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by New Covenant Trust Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.2k 55 58.78

More positions owned by New Covenant Trust Company

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard World Esg Us Stk Etf (ESGV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard World Esg Intl Stk Etf (VSGX)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Ishares Tr Msci Usa Esg Slc (SUSA)
Amazon (AMZN)
Fidelity Covington Trust Fundamental Larg (FFLC)
Vanguard Index Fds Sm Cp Val Etf (VBR)

View all positions for New Covenant Trust Company

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
BlackRock
State Street Corporation
T. Rowe Price Investment Management
Jennison Associates
Octagon Capital Advisors
Jpmorgan Chase & Co
Deep Track Capital
Logos Global Management
FMR
Morgan Stanley
Deutsche Bank Aktiengesellschaft

View all funds holding Apellis Pharmaceuticals